Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.
Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.
复制标题
DOI:
10.1093/jnci/djp078
复制
发表时间:
2009-05
期刊:
影响因子:
--
通讯作者:
Xiangsheng Zuo;Zhanglong Peng;M. Moussalli;Jeffrey S. Morris;R. Broaddus;S. Fischer;I. Shureiqi
中科院分区:
文献类型:
--
作者:
Xiangsheng Zuo;Zhanglong Peng;M. Moussalli;Jeffrey S. Morris;R. Broaddus;S. Fischer;I. Shureiqi
Peroxisome proliferator-activated receptor-delta (PPAR-delta) is overexpressed in human colon cancer, but its contribution to colonic tumorigenesis is controversial. We generated a mouse model in which PPAR-delta was genetically disrupted in colonic epithelial cells by targeted deletion of exon 4. Elimination of colon-specific PPAR-delta expression was confirmed by real-time reverse transcription-polymerase chain reaction (real-time RT-PCR), immunoblotting, and activity assays. Mice with and without targeted PPAR-delta genetic disruption (10-11 mice per group) were tested for incidence of azoxymethane-induced colon tumors. The effects of targeted PPAR-delta deletion on vascular endothelial growth factor expression were determined by real-time RT-PCR. Targeted PPAR-delta genetic disruption inhibited colonic carcinogenesis: Mice with PPAR-delta((-/-)) colons developed 98.5% fewer tumors than wild-type mice (PPAR-delta((-/-)) vs wild-type, mean = 0.1 tumors per mouse vs 6.6 tumors per mouse, difference = 6.5 tumors per mouse, 95% confidence interval = 4.9 to 8.0 tumors per mouse, P < .001, two-sided test). Increased expression of vascular endothelial growth factor in colon tumors vs normal colon was suppressed by loss of PPAR-delta expression. These findings indicate that PPAR-delta has a crucial role in promoting colonic tumorigenesis.